Skip to main content

Table 3 Comparison of noncontrast computed tomography features among absorbable benign, nonabsorbable benign, and malignant subsolid nodules

From: Clinical and non-contrast computed tomography characteristics and disease development in patients with benign pulmonary subsolid nodules with a solid component ≤ 5 mm

Characteristics

AB-SSNs (n = 69)

NB-SSNs (n = 70)

M-SSNs (n = 297)

p1*

p2*

p3*

Location

   

0.949 a

0.214 a

0.244 a

 Upper lobe

44 (63.77%)

45 (64.29%)

212 (71.38%)

   

 Middle/lower lobe

25 (36.23%)

25 (35.71%)

85 (28.62%)

   

Size (mm)

   

0.123 b

0.019 b

 < 0.001 b

 Average

10.00 ± 6.00

9.00 ± 5.00

11.00 ± 4.00

   

 Range

5–23

5–21

8–27

   

Margin

   

 < 0.001 a

 < 0.001 a

0.661 a

 Well-defined

9 (13.04%)

39 (55.71%)

174 (58.59%)

   

 Ill-defined

60 (86.96%)

31 (44.29%)

123 (41.41%)

   

Shape

   

0.556 a

 < 0.001 a

 < 0.001a

 Regular

39 (56.52%)

43 (61.43%)

243 (81.82%)

   

 Irregular

30 (43.48%)

27 (38.57%)

54 (18.18%)

   

Density

   

0.554 a

0.566 a

0.183 a

 GGO

34 (49.28%)

38 (54.29%)

135 (45.45%)

   

 PSO

35 (50.72%)

32 (45.71%)

162 (54.55%)

   

CT value of GGO areas (HU)

 − 633.04 ± 117.31

 − 635.53 ± 112.98

 − 592.00 ± 167.00

0.899 c

0.001 b

 < 0.001b

Target sign

12 (17.39%)

9 (12.86%)

11 (3.70%)

0.455 a

 < 0.001 a

0.006 a

Air bronchogram

4 (5.80%)

4 (5.71%)

33 (11.11%)

1.000 a

0.187 a

0.177 a

Bubble lucency

0 (0%)

2 (2.86%)

44 (14.81%)

0.496 a

0.001 a

0.007 a

Abnormal intranodular vessel sign

7 (10.14%)

9 (12.86%)

46 (15.49%)

0.616 a

0.256 a

0.579 a

Thickened interlobular septa

6 (8.70%)

1 (1.43%)

3 (1.01%)

0.116 a

0.001 a

0.573 a

Satellite lesions

9 (13.04%)

4 (5.71%)

11 (3.70%)

0.138 a

0.005 a

0.668 a

Pleural retraction

2 (2.90%)

7 (10.00%)

48 (16.16%)

0.175 a

0.004 a

0.194 a

Pleural attachment

13 (18.84%)

13 (18.57%)

65 (21.89%)

0.968 a

0.578 a

0.542 a

  1. AB-SSNs Absorbable benign subsolid nodules, NB-SSNs Nonabsorbable benign subsolid nodules, M-SSNs Malignant subsolid nodules, GGO Ground glass opacity, PSO Part-solid opacity, CT Computed tomography
  2. *Bonferroni correction in which p < 0.017 is significant. p1: the p-value of AB-SSNs vs. NB-SSNs; p2: the p-value of AB-SSNs vs. M-SSNs; p3: the p-value of NB-SSNs vs. M-SSNs
  3. aChi-squared test
  4. bMann–Whitney U test
  5. cTwo independent-sample Student’s t-tests